Recent Company News

• 11:23 AM ET Jun 04, 2026
  

  Transcript Intelligence: Mereo BioPharma Group at Jefferies Global Healthcare Conference ($0.33, 0.00)

• 07:33 AM ET May 12, 2026
  

  Mereo BioPharma Group reports Q1 EPS ($0.01) vs FactSet ($0.01) [6 est, ($0.05)-0.04] ($0.24, 0.00)

• 10:25 PM ET May 11, 2026
  

  Berger Montague Advises Investors to Inquire About Securities Fraud Class Action Against MEREO BIOPHARMA GROUP PLC (MREO)

• 04:30 PM ET Mar 23, 2026
  

  StreetAccount Sector Summary - Healthcare Post-Market

• 08:38 AM ET Mar 23, 2026
  

  StreetAccount Sector Summary - Healthcare Pre-Market

• 06:03 AM ET Mar 23, 2026
  

  Mereo BioPharma Group downgraded to neutral from overweight at JPMorgan ($0.34, 0.00)

• 08:33 AM ET Mar 19, 2026
  

  Mereo BioPharma Group reports FY25 EPS ($0.05) vs FactSet ($0.06) [7 est, ($0.06)-(0.06)] ($0.35, 0.00)

• 05:24 PM ET Jan 14, 2026
  

  Transcript Intelligence: Mereo BioPharma Group at J.P. Morgan Healthcare Conference ($0.72, 0.00)

• 08:26 AM ET Jan 12, 2026
  

  Mereo BioPharma provides corporate update ($0.49, 0.00)

• 04:53 PM ET Jan 02, 2026
  

  StreetAccount Sector Summary - Healthcare Weekly Recap